chr1-197101391-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_018136.5(ASPM):​c.7860G>C​(p.Gln2620His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0663 in 1,608,614 control chromosomes in the GnomAD database, including 4,194 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q2620K) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.049 ( 237 hom., cov: 32)
Exomes 𝑓: 0.068 ( 3957 hom. )

Consequence

ASPM
NM_018136.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9O:1

Conservation

PhyloP100: -0.907

Publications

16 publications found
Variant links:
Genes affected
ASPM (HGNC:19048): (assembly factor for spindle microtubules) This gene is the human ortholog of the Drosophila melanogaster 'abnormal spindle' gene (asp), which is essential for normal mitotic spindle function in embryonic neuroblasts. Studies in mouse also suggest a role of this gene in mitotic spindle regulation, with a preferential role in regulating neurogenesis. Mutations in this gene are associated with microcephaly primary type 5. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2011]
ASPM Gene-Disease associations (from GenCC):
  • microcephaly 5, primary, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0013516843).
BP6
Variant 1-197101391-C-G is Benign according to our data. Variant chr1-197101391-C-G is described in ClinVar as [Benign]. Clinvar id is 21609.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0715 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ASPMNM_018136.5 linkc.7860G>C p.Gln2620His missense_variant Exon 18 of 28 ENST00000367409.9 NP_060606.3 Q8IZT6-1B3KWI2
ASPMNM_001206846.2 linkc.4066-5227G>C intron_variant Intron 17 of 26 NP_001193775.1 Q8IZT6-2B3KWI2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ASPMENST00000367409.9 linkc.7860G>C p.Gln2620His missense_variant Exon 18 of 28 1 NM_018136.5 ENSP00000356379.4 Q8IZT6-1

Frequencies

GnomAD3 genomes
AF:
0.0487
AC:
7385
AN:
151702
Hom.:
237
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0140
Gnomad AMI
AF:
0.0418
Gnomad AMR
AF:
0.0448
Gnomad ASJ
AF:
0.0840
Gnomad EAS
AF:
0.000776
Gnomad SAS
AF:
0.0288
Gnomad FIN
AF:
0.0529
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0732
Gnomad OTH
AF:
0.0572
GnomAD2 exomes
AF:
0.0507
AC:
12506
AN:
246592
AF XY:
0.0515
show subpopulations
Gnomad AFR exome
AF:
0.0130
Gnomad AMR exome
AF:
0.0317
Gnomad ASJ exome
AF:
0.0833
Gnomad EAS exome
AF:
0.000110
Gnomad FIN exome
AF:
0.0533
Gnomad NFE exome
AF:
0.0715
Gnomad OTH exome
AF:
0.0633
GnomAD4 exome
AF:
0.0682
AC:
99283
AN:
1456794
Hom.:
3957
Cov.:
52
AF XY:
0.0674
AC XY:
48851
AN XY:
724822
show subpopulations
African (AFR)
AF:
0.0127
AC:
425
AN:
33406
American (AMR)
AF:
0.0340
AC:
1511
AN:
44486
Ashkenazi Jewish (ASJ)
AF:
0.0805
AC:
2100
AN:
26074
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39548
South Asian (SAS)
AF:
0.0322
AC:
2773
AN:
86178
European-Finnish (FIN)
AF:
0.0564
AC:
2831
AN:
50206
Middle Eastern (MID)
AF:
0.0413
AC:
235
AN:
5690
European-Non Finnish (NFE)
AF:
0.0770
AC:
85531
AN:
1111000
Other (OTH)
AF:
0.0643
AC:
3873
AN:
60206
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
5675
11350
17025
22700
28375
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3196
6392
9588
12784
15980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0486
AC:
7383
AN:
151820
Hom.:
237
Cov.:
32
AF XY:
0.0463
AC XY:
3432
AN XY:
74202
show subpopulations
African (AFR)
AF:
0.0140
AC:
580
AN:
41492
American (AMR)
AF:
0.0447
AC:
679
AN:
15192
Ashkenazi Jewish (ASJ)
AF:
0.0840
AC:
291
AN:
3464
East Asian (EAS)
AF:
0.000778
AC:
4
AN:
5142
South Asian (SAS)
AF:
0.0284
AC:
137
AN:
4818
European-Finnish (FIN)
AF:
0.0529
AC:
560
AN:
10594
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.0732
AC:
4962
AN:
67810
Other (OTH)
AF:
0.0566
AC:
119
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
360
720
1079
1439
1799
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0668
Hom.:
101
Bravo
AF:
0.0474
TwinsUK
AF:
0.0731
AC:
271
ALSPAC
AF:
0.0732
AC:
282
ESP6500AA
AF:
0.0132
AC:
58
ESP6500EA
AF:
0.0697
AC:
599
ExAC
AF:
0.0502
AC:
6084
Asia WGS
AF:
0.0190
AC:
66
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Mar 31, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 31, 2018
SIB Swiss Institute of Bioinformatics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

This variant is interpreted as a Benign - Stand Alone. The following ACMG Tag(s) were applied: BA1 => Allele frequency is >5% in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. BP4 => Multiple lines of computational evidence suggest no impact on gene or gene product (conservation, evolutionary, splicing impact, etc.). -

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 20, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Microcephaly 5, primary, autosomal recessive Benign:2Other:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
2.5
DANN
Benign
0.62
DEOGEN2
Benign
0.031
T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.083
N
LIST_S2
Benign
0.74
T
MetaRNN
Benign
0.0014
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
1.6
L
PhyloP100
-0.91
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-1.3
N
REVEL
Benign
0.084
Sift
Benign
0.14
T
Sift4G
Benign
0.58
T
Polyphen
0.064
B
Vest4
0.063
MutPred
0.19
Loss of ubiquitination at K2618 (P = 0.0801);
ClinPred
0.0079
T
GERP RS
-8.3
Varity_R
0.048
gMVP
0.010
Mutation Taster
=88/12
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12138336; hg19: chr1-197070521; COSMIC: COSV54130527; API